Landes Bioscience

Recommend Human Vaccines to your librarian for 2008. Download form here.

november/december 2008

volume 4| issue 6

Review

Potentiating vaccine immunogenicity by manipulating the HVEM/BTLA pathway and other co-stimulatory and co-inhibitory signals of the immune system

Marcio O. Lasaro and Hildegund C.J. Ertl
Volume: 4 | Issue: 6

Research Paper

Novel linear DNA vaccines induce protective immune responses against lethal infection with influenza virus type A/H5N1

Frédéric Kendirgi, Nadezda E. Yun, Nathaniel S. Linde, Michele A. Zacks, Jeanon N. Smith, Jennifer K. Smith, Harilyn McMicken, Yin Chen and Slobodan Paessler
Volume: 4 | Issue: 6

Recombinant Influenza B virus HA and NA antigens administered in equivalent amounts are immunogenically equivalent and induce equivalent homotypic and broader heterovariant protection in mice than conventional and live influenza vaccines

Bert E. Johansson and Ian C. Brett
Volume: 4 | Issue: 6

Phase 2 clinical trial of three formulations of tetravalent live-attenuated dengue vaccine in flavivirus-naïve adults

Wellington Sun, Dennis Cunningham, Steven S. Wasserman, Judith Perry, J. Robert Putnak, Kenneth H. Eckels, David W. Vaughn, Stephen J. Thomas , Niranjan Kanesa-Thasan, Bruce L. Innis and Robert Edelman
Volume: 4 | Issue: 6

Immunogenicity and Reactogenicity of Two Diphtheria-Tetanus-Acellular Pertussis-Hepatitis B-Inactivated Polio Virus-Haemophilus influenzae Type b Vaccines Administered at 3, 5 and 11–12 Months of Age

Terhi M. Kilpi, Sven Arne Silfverdal, Lennart Nilsson, Ritva Syrjänen, Cesare Belloni, Maria Desole, Chiara Triban, Jann Storsaeter, Maaria Soila and Jeanne-Marie Jacquet
Volume: 4 | Issue: 6

Neither antibody to a group B streptococcal conjugate vaccine nor the vaccine itself is teratogenic in rabbits

Lawrence C. Paoletti, Hilde-Kari Guttormsen, Mildred S. Christian, Alan M. Hoberman and Pamela McInnes
Volume: 4 | Issue: 6

Table of Contents

november/december 2008

volume 4| issue 6

Review

Potentiating vaccine immunogenicity by manipulating the HVEM/BTLA pathway and other co-stimulatory and co-inhibitory signals of the immune system

Research Paper

Novel linear DNA vaccines induce protective immune responses against lethal infection with influenza virus type A/H5N1

Recombinant Influenza B virus HA and NA antigens administered in equivalent amounts are immunogenically equivalent and induce equivalent homotypic and broader heterovariant protection in mice than conventional and live influenza vaccines

Phase 2 clinical trial of three formulations of tetravalent live-attenuated dengue vaccine in flavivirus-naïve adults

Immunogenicity and Reactogenicity of Two Diphtheria-Tetanus-Acellular Pertussis-Hepatitis B-Inactivated Polio Virus-Haemophilus influenzae Type b Vaccines Administered at 3, 5 and 11–12 Months of Age

Neither antibody to a group B streptococcal conjugate vaccine nor the vaccine itself is teratogenic in rabbits

Commentary

Group B streptococcal conjugate vaccine: A timely concept for which the time has come

Immunogenicity of DNA vaccines in humans: It takes two to tango

Molecular and cellular mechanisms of DNA vaccines

Epidemiology of vaccine safety at the individual-level